Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antiemetic Fosaprepitant To Remedy Nausea and Vomiting
NCT06382012Phase 3Recruiting
- Sponsor
- Montefiore Medical Center
- Start
- Nov 2024
- Primary completion
- Mar 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fosaprepitant in nausea ((none)), Vomiting, sponsored by Montefiore Medical Center. Started Nov 2024; status: recruiting.
02
Drugs
fosaprepitant
03
Conditions
nausea ((none))Vomiting
Beyond the preview
Go deeper on NCT06382012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06382012.